These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group. Azimi PH; Barson WJ; Janner D; Swanson R Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436 [TBL] [Abstract][Full Text] [Related]
11. [The combined preparation ampicillin/sulbactam (Unasyn) in the general surgical clinic]. Bogomolova NS; Bronskaia LK Antibiot Khimioter; 1991 Jun; 36(6):15-8. PubMed ID: 1898182 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections. Solbiati M; Danzi MC; D'Orazio C; Bassetti D Chemioterapia; 1988 Dec; 7(6):393-5. PubMed ID: 3219751 [TBL] [Abstract][Full Text] [Related]
13. [The clinical diagnosis and treatment of ascending infections of the genitalia by using the combined preparation ampicillin/sulbactam (Unasyn)]. Eibach HW Antibiot Khimioter; 1991 Jun; 36(6):13-5. PubMed ID: 1832852 [No Abstract] [Full Text] [Related]
14. [New specialty drugs registered in Austria. Unasyn]. Ganzinger U Wien Klin Wochenschr; 1989 Nov; 101(21):754-60. PubMed ID: 2686180 [No Abstract] [Full Text] [Related]
15. [The use of the combined preparation ampicillin/sulbactam (Unasyn) in the therapy of puerperal endometritis]. Nikonov AP; Ankirskaia AS Antibiot Khimioter; 1991 Jun; 36(6):25-7. PubMed ID: 1898185 [No Abstract] [Full Text] [Related]
16. [Clinical aspects of the pharmacokinetics of unasyn (an ampicillin-sulbactam combination]. Kozyrev VN Antibiot Khimioter; 1992 Oct; 37(10):46-51. PubMed ID: 1296537 [No Abstract] [Full Text] [Related]
17. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections. De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811 [TBL] [Abstract][Full Text] [Related]
18. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Betrosian AP; Douzinas EE Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991 [TBL] [Abstract][Full Text] [Related]
19. A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam). Coccolini F; Catena F; Ansaloni L; Ercolani G; Di Saverio S; Gazzotti F; Lazzareschi D; Pinna AD BMC Gastroenterol; 2011 Apr; 11():42. PubMed ID: 21501482 [TBL] [Abstract][Full Text] [Related]
20. Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination. Benson JM; Nahata MC Drug Intell Clin Pharm; 1988; 22(7-8):534-41. PubMed ID: 3046887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]